Intra-Cellular Therapies competitors

Intra-Cellular Therapies's competitors include Kymab, Hancock Jaffe, Nuo Therapeutics and SomaLogic
Add company...
Intra-Cellular Therapies
Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.
Kymab
Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics.
Hancock Jaffe
Hancock Jaffes is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD).
Nuo Therapeutics
Nuo Therapeutics, Inc. is a biomedical company that pioneers leading-edge biodynamic therapies within the emerging opportunities of a changing healthcare landscape.
SomaLogic
SomaLogic's breakthrough SOMAscan(tm) technology unlocks protein biomarkers for life sciences research, drug discovery and development, and new diagnostics.
Founding Date
Founding Date
2002
Founding Date
2009
Founding Date
1987
Founding Date
N/A
Founding Date
2000
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
New York, US HQ
Locations
Babraham, GB HQ
Taipei, TW
Locations
Irvine, US HQ
Locations
Gaithersburg, US HQ
Locations
Boulder, US HQ
Employees
Employees
41
Employees
1461% increase
Employees
9
Employees
46
Employees
2012% increase
Valuation ($)
Valuation ($)
1.2 b
Valuation ($)
N/A
Valuation ($)
49.9 m
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$245.8k (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$472.4k (FY, 2016)
Revenue (est.)
N/A
Net income
Net income
($97.8m) (FY, 2017)
Net income
N/A
Net income
N/A
Net income
($5.7m) (FY, 2016)
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 100m (over 1 year ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 200m (6 months ago)
Total funding raised
Total funding raised
$ 225.3m
Total funding raised
$ 220.4m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 541.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Kymab
HQ
Babraham, GB
Employees
146↑ 1% increase

Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics.

View company
Hancock Jaffe
HQ
Irvine, US
Employees
9

Hancock Jaffes is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD).

View company
Nuo Therapeutics
HQ
Gaithersburg, US
Employees
46

Nuo Therapeutics, Inc. is a biomedical company that pioneers leading-edge biodynamic therapies within the emerging opportunities of a changing healthcare landscape.

View company
SomaLogic
HQ
Boulder, US
Employees
201↑ 2% increase

SomaLogic's breakthrough SOMAscan(tm) technology unlocks protein biomarkers for life sciences research, drug discovery and development, and new diagnostics.

View company